Why doctors don’t want to treat people with HIV-AIDS

Medical professionals have long avoided treating people with the deadly virus.

They say they want to keep the public safe and are increasingly seeing the pandemic spread faster than doctors can handle.

But as the pandemics have escalated and medical officials become increasingly frustrated, some medical professionals say they are starting to treat the virus with caution.

The CDC is looking at new approaches, including a trial of two drugs that use a virus that can kill HIV-positive people.

In the trial, researchers have injected patients with a drug that is already approved by the FDA to treat other infections.

If approved, it could be used to treat more than 700,000 people who have tested positive for HIV and have not received the new drugs.

On Monday, doctors will start the first of the two drugs, called AZT-2, to treat a new type of coronavirus called H5N1, said Dr. David Lueck of Brigham and Women’s Hospital in Boston.

Luek said it is unclear when the first trial will begin.

The second drug, called Rituximab, is being developed for the virus.

Lück said that researchers are working with drug companies to develop a drug called dalteparin that is more effective than AZT, which could eventually be used by medical personnel in the field.

Lueck said the trial could take about six months.

HIV-positive patients can expect to see a number of new tests in the coming weeks, Lueks office said.

The first test will include a blood test to check if an individual has HIV.

People infected with the virus can receive other tests that can be given for a variety of conditions, including high cholesterol and diabetes.

More from CNN: Health care providers have said they are increasingly trying to help patients manage the pandems new coronaviruses, which have spread faster and are killing more people each day.

But some medical experts say they have been reluctant to treat patients with HIV, even though it is the second leading cause of death in the United States.

They worry that treating people infected with H5Ns could exacerbate the virus and encourage others to get sicker.